alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 5,326–5,350 of 7,816 matching trials · page 214 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Effectiveness of a Safety App to Respond to Dating Violence for College Women and Their Friends
NCT02236663
Usual Care Safety Planing App; Personalized App-Based Safety Decision Aid
Runs in: United States · 4 sites 		NA
other		 COMPLETED 649 Johns Hopkins University
OTHER		 2020-06-02
A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol
NCT03274817
Escitalopram Pill; Venlafaxine Pill; Placebo Oral Tablet
Runs in: United States · 1 site 		PHASE1
other		 TERMINATED 5 NYU Langone Health
OTHER		 2020-06-02
Develop Novel Phototherapy for Health Care of Patients With Sleep Disorder, Mild Cognitive Impairment, or Dementia
NCT04407351
Green LED light; Red LED light (placebo)
Runs in: Taiwan · 1 site 		NA
other		 COMPLETED 51 Kaohsiung Medical University
OTHER		 2020-05-29
Cognitive Ability Training for Seniors With Mild Cognitive Impairment
NCT02940457
Verum tDCS; Sham tDCS
Runs in: Germany · 1 site 		NA
other		 WITHDRAWN 0 Wuerzburg University Hospital
OTHER		 2020-05-26
Combined Subthalamic and Nucleus Basalis Meynert Deep Brain Stimulation for Parkinson's Disease With Dementia
NCT02589925
Vercise deep brain stimulation; subthalamic nucleus (STN) stimulati...
Runs in: Germany · 1 site 		NA
other		 UNKNOWN 10 Wuerzburg University Hospital
OTHER		 2020-05-22
Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)
NCT02708186
Nelotanserin; Placebo
Runs in: United States · 23 sites 		PHASE2
other		 COMPLETED 34 Axovant Sciences Ltd.
INDUSTRY		 2020-05-20
Evaluating Cognitive and Functional Impairment in Alzheimer's Dementia With a Ketogenic Diet.
NCT04396015
Bulletproof Brain Octane; Placebo 		NA
other		 COMPLETED 20 University of Alberta
OTHER		 2020-05-20
Connectomics in Psychiatric Classification
NCT03967535
MRI Brain Imaging; Mental Health Assessment and Computerized Cognitive Test
Runs in: United States · 1 site 		NA
other		 COMPLETED 30 Washington University School of Medicine
OTHER		 2020-05-19
Transcranial Magnetic Stimulation in Primary Progressive Aphasia
NCT03580954
Transcranial Magnetic Stimulation
Runs in: Spain · 1 site 		NA
other		 COMPLETED 20 Hospital San Carlos, Madrid
OTHER		 2020-05-14
Multimodal Imaging in the Study of Disorientation in the Hospital
NCT04387357
Runs in: Germany · 1 site 		NA
other		 UNKNOWN 50 University Medical Center Rostock
OTHER		 2020-05-13
Monetary Cost of Alzheimer's Disease in China
NCT02694445
observation
Runs in: China · 1 site 		NA
other		 COMPLETED 3,098 Beijing Friendship Hospital
OTHER		 2020-05-12
Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease
NCT04213391
sulforaphane; Placebo
Runs in: China · 1 site 		NA
other		 UNKNOWN 160 Second Affiliated Hospital, Zhejiang University, School of Medicine
OTHER		 2020-05-12
Effect of Hearing Loss and Vestibular Decline on Cognitive Function in Older Subjects
NCT04385225
Longitudinal follow-up
Runs in: Belgium · 1 site 		NA
other		 UNKNOWN 300 University Hospital, Antwerp
OTHER		 2020-05-12
Treating Alzheimer's and Dementia With D-ribose
NCT02260141
d-ribose
Runs in: United States · 1 site 		NA
other		 TERMINATED 3 Practitioners Alliance Network
OTHER		 2020-05-08
Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
NCT02260167
A mix of natural treatments and medications
Runs in: United States · 1 site 		NA
other		 COMPLETED 25 Practitioners Alliance Network
OTHER		 2020-05-08
Gait Analysis by Induced Disorientation in a VR Environment
NCT04134806
Runs in: Germany · 1 site 		NA
other		 UNKNOWN 80 University Medical Center Rostock
OTHER		 2020-05-08
The Effect of Different Virtual Reality Trainings on Gait, Balance and Posture of Individuals With Dementia
NCT04377191
exergame; exergame; exercise
Runs in: Turkey (Türkiye) · 1 site 		NA
other		 COMPLETED 30 Ankara Yildirim Beyazıt University
OTHER		 2020-05-07
Amyloid Plaque and Tangle Imaging in Aging and Dementia
NCT00355498
Runs in: United States · 1 site 		NA
other		 COMPLETED 170 University of California, Los Angeles
OTHER		 2020-05-06
Quantitative EEG Markers in Mild Cognitive Impairment in Epilepsy
NCT04376671
Electroencephalography
Runs in: Egypt · 1 site 		NA
other		 COMPLETED 90 Mansoura University Hospital
OTHER		 2020-05-06
A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod
NCT02215616
Laquinimod; Placebo
Runs in: Canada; Czechia; Germany; Italy; Netherlands; Portugal; R... · 53 sites 		PHASE2
other		 COMPLETED 352 Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY		 2020-05-04
Development of Assessments for Later Stage HD
NCT04370470
Runs in: United Kingdom; United States · 20 sites 		NA
other		 UNKNOWN 340 CHDI Foundation, Inc.
OTHER		 2020-05-01
A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease
NCT03462121
RPh201; Placebo
Runs in: Canada · 5 sites 		PHASE2
other		 COMPLETED 83 Regenera Pharma Ltd
INDUSTRY		 2020-04-30
Efficacy of Hypnosis on Pain and Anxiety During Lumbar Puncture for Etiological Diagnosis of Cognitive Impairment
NCT04368572
Hypnosis
Runs in: France · 1 site 		NA
other		 UNKNOWN 60 Gérond'if
OTHER		 2020-04-30
CBT for African Americans With Cognitive Impairment
NCT03384069
Group-based Cognitive Behavioral Therapy (CBT); Phone-based Cogniti...
Runs in: United States · 1 site 		NA
other		 COMPLETED 31 Emory University
OTHER		 2020-04-29
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
NCT02910102
RVT-101 35 mg; Placebo
Runs in: United States · 11 sites 		PHASE2
other		 COMPLETED 38 Axovant Sciences Ltd.
INDUSTRY		 2020-04-28

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →